APA

Yap T. A., Olmos D., Brunetto A. T., Tunariu N., Barriuso J., Riisnaes R., Pope L., Clark J., Futreal A., Germuska M., Collins D., deSouza N. M., Leach M. O., Savage R. E., Waghorne C., Chai F., Garmey E., Schwartz B., Kaye S. B. & de Bono J. S. (20110527). Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Yap Timothy A, Olmos David, Brunetto Andre T, Tunariu Nina, Barriuso Jorge, Riisnaes Ruth, Pope Lorna, Clark Jeremy, Futreal Andrew, Germuska Michael, Collins David, deSouza Nandita M, Leach Martin O, Savage Ronald E, Waghorne Carol, Chai Feng, Garmey Edward, Schwartz Brian, Kaye Stan B and de Bono Johann S. 20110527. Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Yap T. A., Olmos D., Brunetto A. T., Tunariu N., Barriuso J., Riisnaes R., Pope L., Clark J., Futreal A., Germuska M., Collins D., deSouza N. M., Leach M. O., Savage R. E., Waghorne C., Chai F., Garmey E., Schwartz B., Kaye S. B. and de Bono J. S. (20110527). Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Yap Timothy A, Olmos David, Brunetto Andre T, Tunariu Nina, Barriuso Jorge, Riisnaes Ruth, Pope Lorna, Clark Jeremy, Futreal Andrew, Germuska Michael, Collins David, deSouza Nandita M, Leach Martin O, Savage Ronald E, Waghorne Carol, Chai Feng, Garmey Edward, Schwartz Brian, Kaye Stan B and de Bono Johann S. Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20110527.